-+ 0.00%
-+ 0.00%
-+ 0.00%

Cognition Therapeutics Q3 EPS $(0.04) Beats $(0.07) Estimate

Benzinga·11/05/2026 11:03:56
Listen to the news
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 33.33 percent increase over losses of $(0.06) per share from the same period last year.